Did not become law. It stopped in the Senate's Budget and Appropriations Committee on June 17, 2019. The 2018–2019 session has ended.
2018–2019 Session
Senate Bill 2387
Requires pharmaceutical manufacturers and wholesale distributors to report certain manufacturing and dispensing information concerning prescription opioid drugs, medication-assisted treatment drugs, and opioid antidote drugs.*
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor from Mar 26
Its course
April 5, 2018 to June 17, 2019, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action3 actions on 2 days
In the SenateApr 5 to Jun 17 · stopped438 days
Health, Human Services and Senior CitizensApr 5 to Jun 17438 days
Budget and AppropriationsJun 17 to Jun 17 · stopped0 days
Amendments
Each amendment offered, and what became of it.
Senate committee amendmentAdopted
Adopted Jun 17, 2019
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the Senate Apr 5 – Jun 17, 2019
- Apr 5Introduced in the Senate and sent to Health, Human Services and Senior Citizens
- Jun 17, 2019Health, Human Services and Senior Citizens recommended it as amended
- Read a second time
- Sent to Budget and Appropriations